Effects of the CCR5-Δ32 mutation on antiviral treatment in chronic hepatitis C
To access this article, please choose from the options below
PII: S0168-8278(03)00193-4
doi:10.1016/S0168-8278(03)00193-4
© 2003 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
